Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1959-1972
Author(s):
S. Brunelleschi, L. Penengo, M. M. Santoro and G. Gaudino
Tumor Cell-Based Vaccination in Renal Cell Carcinoma: Rationale,Approaches, and Recent Clinical Development
Journal:
Current Drug Targets
Volume:
3
Page:
401-408
Author(s):
Johannes Volk, Saadettin Sel, Arnold Ganser and Patrick Schoffski
Functional Genomics Approaches in Cancer Research
Journal:
Current Genomics
Volume:
3
Page:
425-436
Author(s):
Patrice J. Morin
Whole-Body Autoradiography In Drug Discovery
Journal:
Current Drug Metabolism
Volume:
3
Page:
451-462
Author(s):
E. G. Solon, S. K. Balani and F. W. Lee
The Influence of DMPK as an Integrated Partner in Modern Drug Discovery
Journal:
Current Drug Metabolism
Volume:
3
Page:
527-550
Author(s):
Robert J. Riley, Iain J. Martin and Anne E. Cooper
The Importance of Growth Hormone (GH) and GH Secretagogues for Bone Mass and Density
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2023-2032
Author(s):
Johan Svensson
SERMs: Evolutionary Chemistry, Revolutionary Biology
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2089-2111
Author(s):
Chris P. Miller
Experience with Indium-111 and Yttrium-90-Labeled Somatostatin Analogs
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1781-1807
Author(s):
I. Virgolini, T. Traub, C. Novotny, M. Leimer, B. Fuger, S. R. Li, P. Patri, T. Pangerl, P. Angelberger, M. Raderer, G. Burggasser, F. Andreae, A. Kurtaran and R. Dudczak
Diagnostic and Therapeutic Applications of Radiolabeled Somatostatin Analogs: Current Status in an Oncology Center
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1809-1814
Author(s):
Donald A. Podoloff
Gene Therapy Approaches for the Selective Killing of Cancer Cells
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1683-1694
Author(s):
Eva Maria Westphal and Harald von Melchner